NCT01076972 - Drug Use Investigation of Kaletra | Biotech Hunter

Enrollment

1,184

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Human Immunodeficiency Virus

Interventions

DRUG

Lopinavir/ritonavir (Kaletra)

Lopinavir/ritonavir evaluated separately in patients who were naive to previous antiretroviral treatment and those who were not.

Trial Locations (29)

Site Reference ID/Investigator# 36516, Aichi

Site Reference ID/Investigator# 36517, Aichi

Site Reference ID/Investigator# 36518, Chiba

Site Reference ID/Investigator# 36519, Fukuoka

Site Reference ID/Investigator# 36521, Fukuoka

Site Reference ID/Investigator# 36522, Hiroshima

Site Reference ID/Investigator# 36523, Hokkaido

Site Reference ID/Investigator# 36524, Hyōgo

Site Reference ID/Investigator# 36525, Kanagawa

Site Reference ID/Investigator# 36526, Kyoto

Site Reference ID/Investigator# 36622, Miyagi

Site Reference ID/Investigator# 36623, Miyagi

Site Reference ID/Investigator# 36624, Niigata

Site Reference ID/Investigator# 36625, Okayama

Site Reference ID/Investigator# 36626, Osaka

Site Reference ID/Investigator# 36627, Osaka

Site Reference ID/Investigator# 36628, Shizuoka

Site Reference ID/Investigator# 36629, Tokyo

Site Reference ID/Investigator# 36630, Tokyo

Site Reference ID/Investigator# 36631, Tokyo

Site Reference ID/Investigator# 36632, Tokyo

Site Reference ID/Investigator# 36633, Tokyo

Site Reference ID/Investigator# 36634, Tokyo

Site Reference ID/Investigator# 36635, Tokyo

Site Reference ID/Investigator# 36636, Tokyo

Site Reference ID/Investigator# 36637, Tokyo

Site Reference ID/Investigator# 36638, Tokyo

Site Reference ID/Investigator# 36639, Tokyo

Site Reference ID/Investigator# 5342, Tokyo